Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
India · Delayed Price · Currency is INR 86.04
-0.04 (-0.05%)
Jul 21, 2026, 3:30 PM IST
NSE:NIVABUPA Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, NSE:NIVABUPA stock has a consensus rating of "Buy" and an average price target of ₹93.82. The average 1-year stock price forecast is 9.04% higher than the current stock price, while the lowest is ₹85.00 (-1.21%) and the highest is ₹105.00 (+22.04%).
Price Target: ₹93.82 (+9.04%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:NIVABUPA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹95.00 → ₹100.00 | Buy | Maintains | ₹95.00 → ₹100.00 | +16.23% | Jul 8, 2026 |
| Motilal Oswal | Motilal Oswal | Buy Maintains ₹100.00 | Buy | Maintains | ₹100.00 | +16.23% | Jun 19, 2026 |
Financial Forecast
Revenue This Year
98.03B
from 84.43B
Increased by 16.10%
Revenue Next Year
119.90B
from 98.03B
Increased by 22.32%
EPS This Year
1.71
from 0.71
Increased by 140.97%
EPS Next Year
2.65
from 1.71
Increased by 54.99%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.